Newsstand Menu

CSHL Story archive for Tag: Christopher Vakoc

Researchers discover new type of lung cancer

Researchers discover new type of lung cancer

June 25, 2018

CRISPR-based system identifies important new drug targets in a deadly leukemia

CRISPR-based system identifies important new drug targets in a deadly leukemia

March 8, 2018

Molecular decoy helps researchers halt and reverse acute leukemia in mice

Molecular decoy helps researchers halt and reverse acute leukemia in mice

January 8, 2018

Friends of T.J. present $50,000 gift for ongoing rhabdomyosarcoma research

Friends of T.J. present $50,000 gift for ongoing rhabdomyosarcoma research

November 7, 2017

Halfway around the world, a reunion of friends opens door to a cancer discovery

Halfway around the world, a reunion of friends opens door to a cancer discovery

August 31, 2017

Chris Vakoc

Chris Vakoc

July 29, 2017

Cold Spring Harbor Laboratory Sarcoma Research Update

Cold Spring Harbor Laboratory Sarcoma Research Update

January 4, 2017

Why calling childhood cancers “rare” is missing the point

Why calling childhood cancers “rare” is missing the point

September 19, 2016

Academic-industry collaboration generates elegant way of pinpointing how a new drug exerts beneficial effects

Academic-industry collaboration generates elegant way of pinpointing how a new drug exerts beneficial effects

July 5, 2016

Pershing Square Sohn Cancer Research Alliance awards prize to CSHL’s Christopher Vakoc

Pershing Square Sohn Cancer Research Alliance awards prize to CSHL’s Christopher Vakoc

May 27, 2016

Christina Renna Foundation Raises $35,000 for pediatric cancer research at CSHL

Christina Renna Foundation Raises $35,000 for pediatric cancer research at CSHL

January 29, 2016

Clark Gillies Foundation gives $50,000 for sarcoma research at CSHL

Clark Gillies Foundation gives $50,000 for sarcoma research at CSHL

December 30, 2015

Unassuming “Swiss Army knife”-like protein proves lynchpin in a new cancer drug’s therapeutic action

Unassuming “Swiss Army knife”-like protein proves lynchpin in a new cancer drug’s therapeutic action

November 30, 2015

Rhabdomyosarcoma (RMS) research bolstered by $50,000 gift from Friends of TJ

Rhabdomyosarcoma (RMS) research bolstered by $50,000 gift from Friends of TJ

October 20, 2015

Pershing Square Foundation establishes $10 million endowment to support CSHL life science research

Pershing Square Foundation establishes $10 million endowment to support CSHL life science research

June 1, 2015